Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group.

Cohen, Kenneth J; Heideman, Richard L; Zhou, Tianni; Holmes, Emiko J; Lavey, Robert S; Bouffet, Eric; Pollack, Ian F

Cohen, Kenneth J; Heideman, Richard L; Zhou, Tianni; Holmes, Emiko J; Lavey, Robert S; Bouffet, Eric; Pollack, Ian F.

Affiliation

Cohen KJ; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, USA. kcohen@jhmi.edu

Neuro Oncol ; 13(4): 410-6, 2011 Apr.

Article in En | MEDLINE | ID: mdl-21345842

Subject(s)

Antineoplastic Agents, Alkylating/therapeutic use; Brain Stem Neoplasms/drug therapy; Dacarbazine/analogs & derivatives; Pons; Adolescent; Brain Stem Neoplasms/radiotherapy; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine/therapeutic use; Female; Humans; Male; Radiotherapy Dosage; Survival Rate; Temozolomide; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pons / Antineoplastic Agents, Alkylating / Brain Stem Neoplasms / Dacarbazine Type of study: Diagnostic_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2011 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google